Skip to main content
SpringerLink
Log in
Book cover

Breast Cancer Epidemiology pp 243–260Cite as

Non-Hormonal Medications and Chronic Diseases

  • Chapter
  • First Online:

  • 2941 Accesses

Abstract

This chapter explores the relation between breast cancer risk and the use of non-hormonal medications and chronic diseases. Many drugs and diseases have been linked with breast cancer in case reports and epidemiologic studies. This chapter covers those major medications and diseases where there is adequate epidemiologic evidence for evaluation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Achiron A, Barak Y, Gail M, Mandel M, Pee D et al (2005) Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Breast Cancer Res Treat 89:265–270

    Article  CAS  PubMed  Google Scholar 

  • ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997

    Article  Google Scholar 

  • Amato MP, Pracucci G, Ponziani G, Siracusa G, Fratiglioni L, Amaducci L (1993) Long-term safety of azathioprine therapy in multiple sclerosis. Neurology 43:831–833

    CAS  PubMed  Google Scholar 

  • Arun B, Miller A, Isaacs K, Saxton KP, Brown P, Elledge R (2005) Accquisition of breast tissue in a biomarker modulation study using bexarotene in women at high risk of breast cancer. J Clin Oncol ASCO Annucal Meeting Proceedings. 23(16S):1002

    Google Scholar 

  • Ashbury FD, Madlensky L, Raich P, Thompson M, Whitney G et al (2003) Antidepressant prescribing in community cancer care. Support Care Cancer 11:278–285

    PubMed  Google Scholar 

  • Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L et al (2005) Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 64:1421–1426

    Article  CAS  PubMed  Google Scholar 

  • Baron JA (2003) Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 37:1–24

    Article  CAS  PubMed  Google Scholar 

  • Beck P, Wysowski DK, Downey W, Butler-Jones D (2003) Statin use and the risk of breast cancer. J Clin Epidemiol 56:280–285

    Article  PubMed  Google Scholar 

  • Bergasa NV (1998) Primary biliary cirrhosis in patients with breast cancer: studying the link. Med Hypotheses 50:465–472

    Article  CAS  PubMed  Google Scholar 

  • Bernatsky S, Boivin JF, Joseph L, St Pierre Y, Moore A, Rajan R, Clarke A (2002) Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. J Rheumatol 29:2551–2554

    PubMed  Google Scholar 

  • Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A et al (2005a) An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52:1481–1490

    Article  CAS  PubMed  Google Scholar 

  • Bernatsky S, Ramsey-Goldman R, Clarke A (2005b) Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin Am 31:387–402

    Article  Google Scholar 

  • Blais L, Desgagne A, LeLorier J (2000) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 160:2363–2368

    Article  CAS  PubMed  Google Scholar 

  • Bonanni B, Lazzeroni M, Veronesi U (2007) Synthetic retinoid fenretinide in breast cancer chemoprevention. Expert Rev Anticancer Ther 7:423–432

    Article  CAS  PubMed  Google Scholar 

  • Bordeleau L, Pritchard K, Goodwin P, Loprinzi C (2007) Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin Ther 29:230–241

    Article  CAS  PubMed  Google Scholar 

  • Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR (2004) The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. Cancer 100:2308–2316

    Article  CAS  PubMed  Google Scholar 

  • Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR (2007) Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev 16:416–421

    Article  CAS  PubMed  Google Scholar 

  • Brandes LJ, Arron RJ, Bogdanovic RP, Tong J, Zaborniak CL et al (1992) Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 52:3796–3800

    CAS  PubMed  Google Scholar 

  • Brtko J (2007) Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention. Cent Eur J Public Health 15:3–6

    CAS  PubMed  Google Scholar 

  • Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC et al (2006) Statin use and breast cancer: prospective results from the Women’s Health Initiative. J Natl Cancer Inst 98:700–707

    Article  CAS  PubMed  Google Scholar 

  • Cauley JA, Zmuda JM, Lui LY, Hillier TA, Ness RB et al (2003) Lipid-lowering drug use and breast cancer in older women: a prospective study. J Womens Health (Larchmt) 12:749–756

    Article  Google Scholar 

  • Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS (2007) Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat 112:123–132

    Article  PubMed  CAS  Google Scholar 

  • Confavreux C, Saddier P, Grimaud J, Moreau T, Adeleine P, Aimard G (1996) Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 46:1607–1612

    CAS  PubMed  Google Scholar 

  • Coogan PF (2006) Review of the epidemiological literature on antidepressant use and breast cancer risk. Expert Rev Neurother 6:1363–1374

    Article  CAS  PubMed  Google Scholar 

  • Coogan PF, Rosenberg L, Strom BL (2007) Statin use and the risk of 10 cancers. Epidemiology 18:213–219

    Article  PubMed  Google Scholar 

  • Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM et al (2005) Low-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trial. JAMA 294:47–55

    Article  CAS  PubMed  Google Scholar 

  • Cotterchio M, Kreiger N, Darlington G, Steingart A (2000) Antidepressant medication use and breast cancer risk. Am J Epidemiol 151:951–957

    CAS  PubMed  Google Scholar 

  • Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167

    Article  PubMed  Google Scholar 

  • Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S et al (2005) Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103:1122–1128

    Article  CAS  PubMed  Google Scholar 

  • Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (2006) Statins and cancer risk: a meta-analysis. JAMA 295:74–80

    Article  CAS  PubMed  Google Scholar 

  • Daling JR (1996) Calcium channel blockers and cancer: is an association biologically plausible?. Am J Hypertens 9:713–714

    Article  CAS  PubMed  Google Scholar 

  • Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM (2005) Statins and cancer prevention. Nat Rev Cancer 5:930–942

    Article  CAS  PubMed  Google Scholar 

  • Didham RC, Reith DM, McConnell DW, Harrison KS (2005) Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Res Treat 92:163–167

    Article  CAS  PubMed  Google Scholar 

  • Duncan RE, El-Sohemy A, Archer MC (2007) Statins and cancer. Epidemiology 18:520

    Article  PubMed  Google Scholar 

  • Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88:988–993

    Article  CAS  PubMed  Google Scholar 

  • Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2005) Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med 165:2264–2271

    Article  CAS  PubMed  Google Scholar 

  • Extermann M (2007) Interaction between comorbidity and cancer. Cancer Control 14:13–22

    PubMed  Google Scholar 

  • Felmeden DC, Lip GY (2001) Antihypertensive therapy and cancer risk. Drug Saf 24:727–739

    Article  CAS  PubMed  Google Scholar 

  • Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL (1997) Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 80:1438–1447

    Article  CAS  PubMed  Google Scholar 

  • Friedman GD, Oestreicher N, Chan J, Quesenberry CP Jr, Udaltsova N, Habel LA (2006) Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer Epidemiol Biomarkers Prev 15:2102–2106

    Article  CAS  PubMed  Google Scholar 

  • Friis S, Poulsen AH, Johnsen SP, McLaughlin JK, Fryzek JP et al (2005) Cancer risk among statin users: a population-based cohort study. Int J Cancer 114:643–647

    Article  CAS  PubMed  Google Scholar 

  • Friis S, Sorensen HT, Mellemkjaer L, McLaughlin JK, Nielsen GL et al (2001) Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer 92:2462–2470

    Article  CAS  PubMed  Google Scholar 

  • Friis S, Thomassen L, Sorensen HT, Tjonneland A, Overvad K, Cronin-Fenton DP et al (2008) Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur J Cancer Prev 17:88–96

    Article  PubMed  Google Scholar 

  • Fryzek JP, Poulsen AH, Lipworth L, Pedersen L, Norgaard M et al (2006) A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat 97:231–236

    Article  PubMed  Google Scholar 

  • Garcia Rodriguez LA, Gonzalez-Perez A (2005) Use of antibiotics and risk of breast cancer. Am J Epidemiol 161:616–619

    Article  CAS  PubMed  Google Scholar 

  • Gierach GL, Lacey JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR et al (2008) Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res 10:R38 (doi: 10.1186/bcr2089)

    Article  PubMed  CAS  Google Scholar 

  • Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN (2007) Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol 166:1150–1158

    Article  PubMed  Google Scholar 

  • Goldman MB (1990) Thyroid diseases and breast cancer. Epidemiol Rev 12:16–28

    CAS  PubMed  Google Scholar 

  • Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 3:28

    Article  PubMed  Google Scholar 

  • Gonzalez-Perez A, Ronquist G, Garcia Rodriguez LA (2004) Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf 13:581–585

    Article  PubMed  Google Scholar 

  • Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ (2004) The risk of cancer in users of statins. J Clin Oncol 22:2388–2394

    Article  CAS  PubMed  Google Scholar 

  • Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO et al (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85:307–311

    Article  CAS  PubMed  Google Scholar 

  • Grossman E, Messerli FH, Goldbourt U (2001) Antihypertensive therapy and the risk of malignancies. Eur Heart J 22:1343–1352

    Article  CAS  PubMed  Google Scholar 

  • Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL et al (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women’s Health Initiative. Cancer Res 63:6096–6101

    CAS  PubMed  Google Scholar 

  • Horwitz RI, Feinstein AR (1985) Exclusion bias and the false relationship of reserpine and breast cancer. Arch Intern Med 145:1873–1875

    Article  CAS  PubMed  Google Scholar 

  • Howel D, Metcalf JV, Gray J, Newman WL, Jones DE, James OF (1999) Cancer risk in primary biliary cirrhosis: a study in northern England. Gut 45:756–760

    Article  CAS  PubMed  Google Scholar 

  • Hudson AG, Gierach GL, Modugno F, Simpson J, Wilson JW, Evans RW et al (2008) Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:680–687

    Article  CAS  PubMed  Google Scholar 

  • Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE (2007) A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99:608–615

    Article  CAS  PubMed  Google Scholar 

  • Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev 11:1586–1591

    CAS  PubMed  Google Scholar 

  • Kaye JA, Jick H (2004) Statin use and cancer risk in the General Practice Research Database. Br J Cancer 90:635–637

    Article  CAS  PubMed  Google Scholar 

  • Kaye JA, Jick H (2005) Antibiotics and the risk of breast cancer. Epidemiology 16:688–690

    Article  PubMed  Google Scholar 

  • Khuder SA, Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84:1188–1192

    Article  CAS  PubMed  Google Scholar 

  • Knekt P, Adlercreutz H, Rissanen H, Aromaa A, Teppo L, Heliovaara M (2000) Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?. Br J Cancer 82:1107–1110

    Article  CAS  PubMed  Google Scholar 

  • Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B (2008) Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Br Cancer Res Treat 109:573–579

    Article  CAS  Google Scholar 

  • Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J et al (2006) Hypertension, diuretics and breast cancer risk. J Hum Hypertens 20:727–732

    Article  CAS  PubMed  Google Scholar 

  • Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT et al (1998) Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?. Lancet 352:179–184

    Article  CAS  PubMed  Google Scholar 

  • Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR (2003) Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65–79 years. Cancer 98:1504–1513

    Article  PubMed  Google Scholar 

  • Lindberg H, Nielsen D, Jensen BV, Eriksen J, Skovsgaard T (2004) Angiotensin converting enzyme inhibitors for cancer treatment?. Acta Oncol 43:142–152

    Article  CAS  PubMed  Google Scholar 

  • Lindgren A, Pukkala E, Tuomilehto J, Nissinen A (2007) Incidence of breast cancer among postmenopausal, hypertensive women. Int J Cancer 121:641–644

    Article  CAS  PubMed  Google Scholar 

  • Lindholm LH, Anderson H, Ekbom T, Hansson L, Lanke J et al (2001) Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet 358:539–544

    Article  CAS  PubMed  Google Scholar 

  • Mangiapane S, Blettner M, Schlattmann P (2008) Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiol Drug Safety 17:115–124

    Article  Google Scholar 

  • Manjer J, Kaaks R, Riboli E, Berglund G (2001) Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 10:33–42

    Article  CAS  PubMed  Google Scholar 

  • Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97:805–812

    Article  CAS  PubMed  Google Scholar 

  • McKenna MC, Zevon MA, Corn B, Rounds J (1999) Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 18:520–531

    Article  CAS  PubMed  Google Scholar 

  • McTiernan A, Wu L, Barnabei VM, Chen C, Hendrix S, Modugno F et al (2008) Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Res Treat 108:217–231

    Article  PubMed  Google Scholar 

  • Meier CR, Derby LE, Jick SS, Jick H (2000) Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med 160:349–353

    Article  CAS  PubMed  Google Scholar 

  • Meier CR, Schmitz S, Jick H (2002) Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy 22:303–309

    Article  CAS  PubMed  Google Scholar 

  • Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH (1996) Rheumatoid arthritis and cancer risk. Eur J Cancer 32A:1753–1757

    Article  CAS  PubMed  Google Scholar 

  • Michels KB, Rosner BA, Walker AM, Stampfer MJ, Manson JE et al (1998) Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the Nurses' Health Study. Cancer 83:2003–2007

    Article  CAS  PubMed  Google Scholar 

  • Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE et al (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26:1752–1758

    Article  PubMed  Google Scholar 

  • Midgard R, Glattre E, Gronning M, Riise T, Edland A, Nyland H (1996) Multiple sclerosis and cancer in Norway. A retrospective cohort study. Acta Neurol Scand 93:411–415

    Article  CAS  PubMed  Google Scholar 

  • Moller H, Kneller RW, Boice JD Jr, Olsen JH (1991) Cancer incidence following hospitalization for multiple sclerosis in Denmark. Acta Neurol Scand 84:214–220

    Article  CAS  PubMed  Google Scholar 

  • National Cancer Institute (1998) http://www.cancer/clinicaltrials.gov. Accessed 7 Nov 2007

  • Nielsen NM, Rostgaard K, Rasmussen S, Koch-Henriksen N, Storm HH et al (2006) Cancer risk among patients with multiple sclerosis: a population-based register study. Int J Cancer 118:979–984

    Article  CAS  PubMed  Google Scholar 

  • Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD (1999) Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology 29:1396–1398

    Article  CAS  PubMed  Google Scholar 

  • Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE (2000) Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens 18:249–254

    Article  CAS  PubMed  Google Scholar 

  • Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM (2008) Statin use and risk of breast cancer. Cancer 112:27–33

    Article  PubMed  Google Scholar 

  • Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T et al (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62:632–635

    CAS  PubMed  Google Scholar 

  • Ron E, Doody MM, Becker DV, Brill AB, Curtis RE et al (1998) Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 280:347–355

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg L, Rao RS, Palmer JR, Strom BL, Stolley PD et al (1998) Calcium channel blockers and the risk of cancer. JAMA 279:1000–1004

    Article  CAS  PubMed  Google Scholar 

  • Seeger H, Wallwiener D, Mueck AO (2003) Statins can inhibit proliferation of human breast cancer cells in vitro. Exp Clin Endocrinol Diabetes 111:47–48

    Article  CAS  PubMed  Google Scholar 

  • Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S (2007) Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation 115:27–33

    Article  CAS  PubMed  Google Scholar 

  • Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J et al (2006) Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 54:2757–2764

    Article  CAS  PubMed  Google Scholar 

  • SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265:3255–3264

    Article  Google Scholar 

  • Simon MS, Tang MT, Bernstein L, Norman SA, Weiss L et al (2002) Do thyroid disorders increase the risk of breast cancer?. Cancer Epidemiol Biomarkers Prev 11:1574–1578

    PubMed  Google Scholar 

  • Singh-Ranger G, Salhab M, Mokbel K (2008) The role of cyclooxygenase-2 in breast cancer: review. Cancer Epidemiol Biomarkers Prev 109:189–198

    CAS  Google Scholar 

  • Smyth PP (2000) Autoimmune thyroid disease and breast cancer: a chance association?. J Endocrinol Invest 23:42–43

    CAS  PubMed  Google Scholar 

  • Sorensen HT, Skriver MV, Friis S, McLaughlin JK, Blot WJ, Baron JA (2005) Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer 92:594–596

    CAS  PubMed  Google Scholar 

  • Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 90:1529–1536

    Article  CAS  PubMed  Google Scholar 

  • Tamim HM, Hanley JA, Hajeer AH, Boivin J, Collet J (2008) Risk of breast cancer in relation to antibiotic use. Pharmarcoepidemiol Drug Safety 17:144–150

    Article  Google Scholar 

  • Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291:2433–2440

    Article  CAS  PubMed  Google Scholar 

  • Thomas E, Brewster DH, Black RJ, Macfarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88:497–502

    Article  CAS  PubMed  Google Scholar 

  • Tworoger S, Eliassen A, Rosner B, Sluss P, Hankinson S (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64:6814–6819

    Article  CAS  PubMed  Google Scholar 

  • Tzioufas AG, Voulgarelis M (2007) Update on Sjogren’s syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 21:989–1010

    Article  CAS  PubMed  Google Scholar 

  • Uray IP, Brown PH (2006) Prevention of breast cancer: current state of the science and future opportunities. Expert Opin Invest Drugs 15:1583–1600

    Article  CAS  Google Scholar 

  • Van der Knaap R, Siemes C, Coebergh JW, van Duijn CM, Hofman A, Stricker BHC (2008) Renin-angiotensin system inhibitors, antiotensin-I-converting enzyme gene iinsertion/deletion polymorphism, and cancer: The Rotterdam Study. Cancer 112:748–757

    Article  Google Scholar 

  • Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH (2004) Antibiotic use in relation to the risk of breast cancer. JAMA 291:827–835

    Article  CAS  PubMed  Google Scholar 

  • Veronesi U, De Palo G, Marubini E, Costa A, Formelli F et al (1999) Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst 91:1847–1856

    Article  CAS  PubMed  Google Scholar 

  • Volpe DA, Ellison CD, Parchment RE, Grieshaber CK, Faustino PJ (2003) Effects of amitriptyline and fluoxetine upon the in vitro proliferation of tumor cell lines. J Exp Ther Oncol 3:169–184

    Article  CAS  PubMed  Google Scholar 

  • Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB et al (1996) Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 98:671–679

    Article  CAS  PubMed  Google Scholar 

  • Weiss SR, McFarland BH, Burkhart GA, Ho PT (1998) Cancer recurrences and secondary primary cancers after use of antihistamines or antidepressants. Clin Pharmacol Ther 63:594–599

    CAS  PubMed  Google Scholar 

  • Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111

    Article  CAS  PubMed  Google Scholar 

  • Wolfe F, Michaud K (2007) Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 56:2886–2895

    Article  PubMed  Google Scholar 

  • Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86(suppl):823S–835S

    CAS  Google Scholar 

  • Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L (2005) Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol 162:165–170

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Slone Epidemiology Center, Boston University, Boston, MA, USA

    Patricia F. Coogan

Authors
  1. Patricia F. Coogan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patricia F. Coogan .

Editor information

Editors and Affiliations

  1. Fairview Ave. N., 1100, Seattle, 98109, U.S.A.

    Christopher Li

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Coogan, P.F. (2010). Non-Hormonal Medications and Chronic Diseases. In: Li, C. (eds) Breast Cancer Epidemiology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0685-4_11

Download citation

Publish with us

Policies and ethics

Search

Navigation